Cargando…
Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar
Myanmar is an endemic country for the Japanese encephalitis virus (JEV), and the SA-14-14-2 live-attenuated JEV vaccine was first introduced as a catch-up vaccination campaign in 2017. To determine the effectiveness of vaccination by means of neutralizing antibody titers against JEV, a cross-section...
Autores principales: | Ngwe Tun, Mya Myat, Kyaw, Aung Kyaw, Nwe, Khine Mya, Inoue, Shingo, Thant, Kyaw Zin, Morita, Kouichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227667/ https://www.ncbi.nlm.nih.gov/pubmed/34072933 http://dx.doi.org/10.3390/vaccines9060568 |
Ejemplares similares
-
Burden of Chikungunya Virus Infection during an Outbreak in Myanmar
por: Ngwe Tun, Mya Myat, et al.
Publicado: (2023) -
Evidence of Chikungunya virus seroprevalence in Myanmar among dengue-suspected patients and healthy volunteers in 2013, 2015, and 2018
por: Luvai, Elizabeth Ajema Chebichi, et al.
Publicado: (2021) -
Detection of East/Central/South African Genotype of Chikungunya Virus in Myanmar, 2010
por: Tun, Mya Myat Ngwe, et al.
Publicado: (2014) -
Detection of genotype-1 of dengue virus serotype 3 for the first time and complete genome analysis of dengue viruses during the 2018 epidemic in Mandalay, Upper Myanmar
por: Ngwe Tun, Mya Myat, et al.
Publicado: (2021) -
Emergence of a Novel Dengue Virus 3 (DENV-3) Genotype-I Coincident with Increased DENV-3 Cases in Yangon, Myanmar between 2017 and 2019
por: Soe, Aung Min, et al.
Publicado: (2021)